Reaction of Estrogen Quinones with Nucleosides
Chem. Res. Toxicol., Vol. 9, No. 5, 1996 853
with a DEC Alpha 3000 workstation equipped with OPUS V
3.1X software and interfaced with the mass spectrometer via a
VG SIOS I unit.
Exact mass measurements were conducted with a Kratos MS-
50 triple analyzer tandem mass spectrometer equipped with a
standard Kratos FAB source (30). The atom beam was 6-7 keV
argon atoms at a total current of 1 mA at the cathode of the
gun. A mixture of CsI and glycerol was used to generate
reference-mass ions for the peak match mode.
6.68 (s, 1H, 1-H), 6.56 (s, 1H, 4-H), 6.36 (t, 1H, J ) 6.7 Hz, 1′-H
[dA]), 5.58 (m, 1H, 6-H), 5.27 (d, 1H, J ) 4.1 Hz, 3′-OH [dA],
exchanged with D2O), 5.17 (t, 1H, J ) 6.0 Hz, 5′-OH [dA],
exchanged with D2O), 4.41 (m, 1H, 3′-H [dA]), 3.88 (m, 1H, 4′-H
[dA]), 3.45-3.59 (m, 2H, 5′-H2 [dA]), 2.73 (q, J ) 6.5 Hz, 1H),
2.38 (dd, J 1 ) 18.5 Hz, J 2 ) 7.5 Hz, 1H), 2.19-2.27 (m, 2H),
1.90-2.16 (m, 4H), 1.84 (t, J ) 9.0 Hz, 1H), 1.73-1.78 (m, 1H),
1.56-1.67 (m, 1H), 1.34-1.49 (m, 3H), 0.81 (s, 3H, 13-CH3). MS,
(M + H)+ C28H34N5O6 calcd 536.25090, found 536.25117.
E1-2,3-Q + d G. A suspension of 2-OHE1 (0.25 mmol) in 5
mL of CH3CN was cooled to -40 °C prior to the addition of
activated MnO2 (2.25 mmol). The suspension was stirred for
10 min and then filtered directly into a stirred solution of dG
(1.30 mmol) in a solvent mixture of 10 mL of CH3CO2H/H2O
(1:1). Aliquots were removed for HPLC analysis at 1, 2, and 5
h to monitor the course of the reaction. After 5 h at room
temperature, solvents were removed under reduced pressure,
and the crude product was dissolved in a 1:1 solvent mixture of
CH3OH/DMF. The product was then isolated via preparative
reverse phase HPLC, as described above, to afford N2-(2-
hydroxyestron-6-yl)deoxyguanosine (2-OHE1-6-N2dG) (10% yield).
2-OHE1-6-N2d G. UV, λmax (nm): 254, 287. 1H NMR (500
MHz): 9.92 (bs, 1H, 1-NH [dG], exchanged with D2O), 8.83 (bs,
2H, 2-OH and 3-OH, exchanged with D2O), 7.91 (s, 1H, 8-H
[dG]), 6.84 (d, 1H, 2-NH [dG], exchanged with D2O), 6.69 (s,
1H, 1-H), 6.64 (s, 1H, 4-H), 6.18 (t, 1H, J ) 6.7 Hz, 1′-H [dG]),
5.29 (d, 1H, J ) 4.0 Hz, 3′-OH [dG], exchanged with D2O), 4.99
(m, 1H, 6-H), 4.87 (t, 1H, J ) 6.0 Hz, 5′-OH [dG], exchanged
with D2O), 4.38 (m, 1H, 3′-H [dG]), 3.81 (m, 1H, 4′-H [dG]), 3.49-
Syn th esis of Estr ogen Nu cleosid e Ad d u cts. E1-3,4-Q or
E2-3,4-Q + d G. A suspension of 4-OHE1 or 4-OHE2 (0.18 mmol)
in 5 mL of CH3CN was cooled to 0 °C prior to the addition of
activated MnO2 (1.18 mmol). The suspension was stirred for
10 min and then filtered directly into a stirred solution of dG
(0.94 mmol) in a solvent mixture of 10 mL of CH3CO2H/H2O
(1:1). Aliquots were removed for HPLC analysis at 1, 2, and 5
h to monitor the course of the reaction. After 5 h at room
temperature, solvents were removed under reduced pressure
and the crude product was dissolved in a 1:1 solvent mixture of
CH3OH/dimethylformamide (DMF). The product was then
isolated via preparative reverse phase HPLC, as described
above, to afford 7-[4-hydroxyestron-1(R,â)-yl]guanine [4-OHE1-
1(R,â)-N7Gua] or 7-[4-hydroxyestradiol-1(R,â)-yl]guanine [4-OHE2-
1(R,â)-N7Gua] (40% yield).
4-OHE1-1(r,â)-N7Gu a . 1H and 13C NMR spectra showed the
product to be a mixture of the designated R and â isomers; the
following spectra are those of the two isomers.
UV, λmax (nm): 211, 291. FTIR (KBr, cm-1): 3430, 2920,
1745, 1700, 1630, 1570, 1480, 1200, 1150, 780. 1H NMR (500
MHz): 10.72 and 10.61 (bs, 1H, 1-NH [Gua], exchanged with
D2O), 9.44 and 9.43 (bs, 1H, 3-OH, exchanged with D2O), 8.50
and 8.49 (bs, 1H, 4-OH, exchanged with D2O), 7.90 and 7.89 (s,
1H, 8-H [Gua]), 6.51 and 6.49 (s, 1H, 2-H), 6.14 and 6.12 (bs,
2H, 2-NH2 [Gua], exchanged with D2O), 2.84 (dd, J 1 ) 17.5 Hz,
J 2 ) 4.0 Hz, 1H), 2.30-2.56 (m, 3H), 1.96-2.02 (m, 1H), 1.83-
1.90 (m, 2H), 1.23-1.61 (m, 4H), 1.10-1.21 (m, 1H), 0.74-0.98
(m, 2H), 0.74 (s, 3H, 13-CH3), 0.45-0.68 (m, 1H). 13C NMR (75
MHz): 162.2, 160.2, 159.9, 153.9, 153.8, 152.9, 152.8, 143.5,
143.2, 143.0, 142.8, 142.1, 142.0, 127.4, 126.3, 126.1, 125.8,
125.7, 113.6, 112.8, 109.3, 108.0, 49.7, 49.4, 47.3, 47.2, 44.2, 43.7,
35.7, 35.1, 32.3, 31.8, 30.7, 25.2, 25.1, 24.4, 24.3, 24.2, 21.1, 13.7,
13.6. MS, (M + H)+ C23H26N5O4 calcd 436.19850, found
436.19863.
3.58 (m, 2H, 5′-H2 [dG]), 2.71 (q, J ) 6.5 Hz, 1H), 2.41 (dd, J 1
)
18.0 Hz, J 2 ) 7.0 Hz, 1H), 2.16-2.28 (m, 2H), 1.98-2.22 (m,
3H), 1.85-1.96 (m, 1H), 1.32-1.18 (m, 6H), 0.85 (s, 3H, 13-CH3).
MS, (M + H)+ C28H34N5O7 calcd 552.24580, found 552.24607.
Resu lts
Syn th esis a n d Str u ctu r e Deter m in a tion of Estr o-
gen Qu in on e Ad d u cts F or m ed w ith Deoxyr ibo-
n u cleosid es. Initial attempts to synthesize nucleoside
adducts of estrogen quinones in aprotic solvents yielded
no adducts. Neither dG nor dA reacted with E1-3,4-Q or
E1-2,3-Q in DMF or Me2SO. In acidic conditions, how-
ever, reaction of estrogen quinones with sulfur nucleo-
philes was previously reported (31). The solvent system
to CH3CO2H/H2O (1:1) facilitated Michael addition of
nucleophilic groups in dG and dA to both E1-3,4-Q and
E1-2,3-Q, to give the products shown in Scheme 2. No
adducts were obtained with deoxycytidine or thymidine.
The quinones were formed in CH3CN at 0 °C for 4-OHE1
and 4-OHE2 and at -40 °C for 2-OHE1 (3) and then
filtered directly into a solution of the nucleoside previ-
ously dissolved in the 1:1 mixture of CH3CO2H/H2O (ca.
pH 2).
Reaction of E1-3,4-Q with dG yielded a product that
eluted as a single peak under several different HPLC
conditions. Reaction yields were typically 40%. The
reaction proceeded to completion after 5 h at room
temperature, and no other adducts were detected. NMR
analysis (detailed discussion below) showed the product
to be a mixture of two conformational isomers attached
to the C1 position of the estrogen A ring and the N7
position of guanine, 4-OHE1-1(R,â)-N7Gua. The genera-
tion of two conformational isomers is the result of a
rotational barrier about the C1-N7Gua bond. Thus, in
one isomer, the guanine moiety is located primarily on
the “R” side of the estrogen ring system, 4-OHE1-1R-
N7Gua, while the other isomer has the guanine moiety
located on the “â” side of the estrogen ring system,
4-OHE1-1â-N7Gua (Figure 1). Rotation from the R
isomer to the â isomer would involve the C8-Gua proton
4-OHE2-1(r,â)-N7Gu a . 1H NMR spectrum showed the prod-
uct to be a mixture of the R and â isomers; the following spectra
are those of the two isomers.
UV, λmax (nm): 211, 292. 1H NMR (500 MHz): 10.72 and
10.64 (bs, 1H, 1-NH [Gua], exchanged with D2O), 9.38 and 9.36
(bs, 1H, 3-OH, exchanged with D2O), 8.44 and 8.43 (bs, 1H,
4-OH, exchanged with D2O), 7.89 and 7.88 (s, 1H, 8-H [Gua]),
6.48 and 6.46 (s, 1H, 2-H), 6.13 and 6.11 (bs, 2H, 2-NH2 [Gua],
exchanged with D2O), 4.39 and 4.35 (d, J ) 3.7 Hz, 1H, 17â-
OH), 4.08 (m, 1H, 17R-H), 2.79 (dd, J 1 ) 17.0 Hz, J 2 ) 4.0 Hz,
1H), 2.30-2.56 (m, 3H), 1.75-1.87 (m, 1H), 1.66-1.75 (m, 1H),
1.46-1.57 (m, 1H), 1.16-1.42 (m, 4H), 0.74 (s, 3H, 13-CH3),
0.48-0.58 (m, 1H). MS, (M + H)+ C23H28N5O4 calcd 438.21410,
found 438.21410.
E1-2,3-Q + d A. A suspension of 2-OHE1 (0.18 mmol) in 5
mL CH3CN was cooled to -40 °C prior to the addition of
activated MnO2 (1.18 mmol). The suspension was stirred for
10 min and then filtered directly into a stirred solution of dA
(0.94 mmol) in a solvent mixture of 10 mL of CH3CO2H/H2O
(1:1). Aliquots were removed for HPLC analysis at 1, 2, and 5
h to monitor the course of the reaction. After 5 h at room
temperature, solvents were removed under reduced pressure,
and the crude product was dissolved in a 1:1 solvent mixture of
CH3OH/DMF. The product was then isolated via preparative
reverse phase HPLC, as described above, to afford N6-(2-
hydroxyestron-6-yl)deoxyadenosine (2-OHE1-6-N6dA) (80% yield).
2-OHE1-6-N6d A. UV, λmax (nm): 207, 276. 1H NMR (300
MHz): 8.61 (s, 1H, OH, exchanged with D2O), 8.57 (s, 1H, OH,
exchanged with D2O), 8.31 and 8.27 (s and bs, 2H, 2-H and 8-H
[dA]), 7.94 (d, 2H, J ) 9.0 Hz, 6-NH [dA], exchanged with D2O),